Muscle and bone disorders represent a tremendous and further increasing health burden affecting the quality of life of millions of people. The mission of Sirana Pharma is to develop therapies for unmet medical needs in musculoskeletal diseases. To accomplish our mission, we pioneer novel biological approaches and mechanisms to generate innovative first-in-class drugs that improve the integrity and function of diseased skeletal muscle and bone tissues.
Scientific Advisory Board
Announcements of corporate news and company updates.
Sirana Pharma will attend the RNA Leaders World Congress live in Basel, March 16-17, 2022. The event is a gathering of leading pharmas and biotechs as well as academic institutions that develop RNA medicines.
Sirana’s CEO Hermann Kaiser, PhD as well as Sirana’s co-founder and CSO Hanna Taipaleenmäki, PhD will participate on the partnering platform.
Sirana Pharma will attend the virtual Biofit conference, December 7-9, 2021. Biofit is one of Europe’s leading events for sourcing early-stage innovations and venture financing. Sirana’s CEO Hermann Kaiser, PhD will participate on the partnering platform.